Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Englert

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Plos One|March 25, 2010
The role of the receptor for advanced glycation end-products in a murine model of silicosisLasse Ramsgaard, Judson M Englert, Jacob Tobolewski, et al.
Plos One|June 2, 2011
Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in miceLasse Ramsgaard, Judson M Englert, Michelle L Manni, et al.
ACS Nano|April 17, 2013
Robust graphene membranes in a silicon carbide frameDaniel Waldmann, Benjamin Butz, Sebastian Bauer, et al.
Scientific Reports|December 22, 2019
Characterizing the maximum number of layers in chemically exfoliated graphenePéter Szirmai, Bence G Márkus, Julio C Chacón-Torres, et al.
The American Journal of Pathology|February 5, 2008
A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosisJudson M Englert, Lana E Hanford, Naftali Kaminski, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 1979
A clinical review of nutritional support of the patientS J Dudrick, E M Copeland, J M Daly, et al.
Science (New York, N.Y.)|November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasionRobert D Leone, Liang Zhao, Judson M Englert, et al.
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2019
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction AdenocarcinomaRonan J Kelly, Jeeyun Lee, Yung-Jue Bang, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Plos One|March 25, 2010
The role of the receptor for advanced glycation end-products in a murine model of silicosisLasse Ramsgaard, Judson M Englert, Jacob Tobolewski, et al.
Plos One|June 2, 2011
Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in miceLasse Ramsgaard, Judson M Englert, Michelle L Manni, et al.
ACS Nano|April 17, 2013
Robust graphene membranes in a silicon carbide frameDaniel Waldmann, Benjamin Butz, Sebastian Bauer, et al.
Scientific Reports|December 22, 2019
Characterizing the maximum number of layers in chemically exfoliated graphenePéter Szirmai, Bence G Márkus, Julio C Chacón-Torres, et al.
The American Journal of Pathology|February 5, 2008
A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosisJudson M Englert, Lana E Hanford, Naftali Kaminski, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 1979
A clinical review of nutritional support of the patientS J Dudrick, E M Copeland, J M Daly, et al.
Science (New York, N.Y.)|November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasionRobert D Leone, Liang Zhao, Judson M Englert, et al.
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2019
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction AdenocarcinomaRonan J Kelly, Jeeyun Lee, Yung-Jue Bang, et al.
Pageof 16